Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subanesthetic esketamine for postoperative sleep disturbance after pain-free oocyte retrieval
ChiCTR2500105998Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Postoperative sleep disturbance (PSD) (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Sleep condition on postoperative day 3. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Postoperative sleep disturbance (PSD)
Beyond the preview
Go deeper on ChiCTR2500105998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105998.